Literature DB >> 3533993

Effective murolytic solubilization of streptococcal-group-specific antigen.

C Lämmler, C Frede, H Blobel.   

Abstract

Streptococcal-group-specific antigens were solubilized with a murolytic enzyme contained in the culture supernatant of Streptomyces globisporus. This facilitated the effective serogrouping of streptococci from humans and animals.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3533993      PMCID： PMC269061          DOI： 10.1128/jcm.24.5.903-904.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  5 in total

1.  Use of autoclaved extracts of hemolytic streptococci for serological grouping.

Authors:  L A RANTZ; E RANDALL
Journal:  Stanford Med Bull       Date:  1955-05

2.  Release of Fc-receptors after streptococcal lysis induced by a lytic enzyme from Streptomyces globisporus.

Authors:  D Tille; G S Chhatwal; H Blobel
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

3.  Lysis of Streptococcus mutans cells with mutanolysin, a lytic enzyme prepared from a culture liquor of Streptomyces globisporus 1829.

Authors:  S Hamada; M Torii; S Kotani; N Masuda; T Ooshima; K Yokogawa; S Kawata
Journal:  Arch Oral Biol       Date:  1978       Impact factor: 2.633

4.  Cell wall preparation consisting of group A carbohydrate and peptidoglycan moieties from Streptococcus pyogenes activates murine B lymphocytes.

Authors:  I Morisaki; S Kimura; M Torii; S M Michalek; J R McGhee; N Okahashi; S Hamada
Journal:  Immunobiology       Date:  1985-11       Impact factor: 3.144

5.  Group B, type III streptococcal cell wall: composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis.

Authors:  B J De Cueninck; G D Shockman; R M Swenson
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441
  5 in total
  1 in total

1.  Comparative studies on Actinomyces pyogenes and Arcanobacterium haemolyticum.

Authors:  C Lämmler; H Blobel
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.